Trial Profile
Effect of Intravenous Administration of C1-inhibitor on Inflammation and Coagulation after Bronchial Instillation of House Dust Mite Allergen and Lipopolysaccharide in Allergic Asthma Patients
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2021
Price :
$35
*
At a glance
- Drugs Complement C1 inhibitor protein (Primary) ; Ciprofloxacin; Metronidazole; Vancomycin
- Indications Allergic asthma
- Focus Pharmacodynamics; Proof of concept
- Acronyms CAST-study
- 23 Jun 2020 Status changed from recruiting to discontinued.
- 02 Sep 2016 Planned number of patients changed from 40 to 60.
- 29 Apr 2015 New trial record